ARCHIVES

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Study: Lack of Sleep Linked With Agressive Breast Cancers

September 28, 2012

Radiotherapy Provides Longer Life To Brain Cancer Patients

May 28, 2010

Preclinical Models: NCI Advisors OK Plan For Mouse Models Consortium

March 13, 1998

In Brief: Balch To Head City of Hope; Rowinsky Moves To San Antonio; Klausner’s Deputy Joins NCI

August 9, 1996

DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts

February 23, 1990

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013